Section Arrow
RPID.NASDAQ
- Rapid Micro Biosystems
Quotes are at least 15-min delayed:2025/04/29 11:19 EDT
Last
 2.33
-0.01 (-0.43%)
Day High 
2.36 
Prev. Close
2.34 
1-M High
2.77 
Volume 
6.10K 
Bid
2.32
Ask
2.34
Day Low
2.295 
Open
2.34 
1-M Low
1.86 
Market Cap 
102.56M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.3 
20-SMA 2.3 
50-SMA 2.57 
52-W High 4.0443 
52-W Low 0.58 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.08/-1.21
Enterprise Value
107.51M
Balance Sheet
Book Value Per Share
1.72
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
28.05M
Operating Revenue Per Share
0.47
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PACBPacific Biosciences of California1.1168-0.0132-1.17%-- 
SENSSenseonics Holdings0.752+0.0304+4.21%-- 
BSXBoston Scientific Corp102.16-0.02-0.02%82.3PE
QSIQuantum-Si1.19-0.02-1.65%-- 
EWEdwards Lifesciences Corp75.7+0.16+0.21%32.28PE
Quotes are at least 15-min delayed:2025/04/29 11:19 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell andgene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.